Skip to main content
Full access
Letters
Published Online: 1 July 2013

Neuroanatomical Abnormalities Before the Onset of Various Types of Delusions in a Patient With Alzheimer Disease

Publication: The Journal of Neuropsychiatry and Clinical Neurosciences
To the Editor: Structural brain abnormalities associated with delusions in Alzheimer Disease (AD) are poorly understood. Also, whether the neural substrate underlying the delusions develops before the onset of the delusions is unclear. Here, we report on an AD patient who developed various types of delusions and who exhibited magnetic resonance imaging (MRI) findings atypical of AD before the onset of the delusions.

Case Report

The patient was a 78-year-old, married, right-handed woman. Around the age of 75 years, her family noticed episodic memory disturbances. At the age of 78 years, she visited our hospital with her family as an outpatient. She was diagnosed as probable AD according to the National Institute of Neurological and Communication Disorders and Stroke/Alzheimer’s Disease and Related Disorders Association (NINCDS/ADRDA) criteria.1 Her Mini-Mental State Exam (MMSE) score was 18/30. She did not exhibit psychotic symptoms at the time of her first visit, and she had no previous history of psychiatric disease. One year later, she developed delusions of theft associated with a delusional jealousy that her husband was having an extramarital affair and that her husband and his lover had stolen her money. Thus, risperidone (0.5 mg/day) was prescribed for her delusions, and the delusions disappeared. However, over the next 6 months, she developed delusional misidentification. She insisted that her daughter was not who she really was. The dose of risperidone was increased to 1 mg/day, which alleviated the delusional misidentification.
At the time of her first visit to our hospital, the patient’s MRI findings were analyzed, using the voxel-based specific regional analysis system for AD (VSRAD), which utilizes a voxel-based morphometry (VBM) analysis.2 Relative to normal controls, significant volume reductions were detected in not only bilateral hippocampal regions, but also bilateral insular cortex, anterior cingulate cortex, right orbitofrontal cortex, and bilateral inferior frontal cortex (Figure 1). A 78-year-old patient with probable AD who did not develop delusions but who had a similar demographic background exhibited significant volume reductions mainly in bilateral hippocampal regions, relative to normal controls. When the second MRI examination was performed after the development of the misidentification delusions, the atrophy showed more progression than that observed during the first MRI examination. The second MRI examination did not show any additional findings, such as hemorrhages.
FIGURE 1. Results Obtained Using the Voxel-Based Specific Regional Analysis System for Alzheimer Disease (VSRAD) [A]: in the Presently-Reported Patient Before the Onset of Delusions; and [B] in a Patient With AD Who Did Not Develop Delusions
[A]: Axial VSRAD (current patient; age 78 years) shows several areas with atrophy, including bilateral insular cortices, the anterior cingulate cortex, the right orbitofrontal cortex, bilateral inferior frontal cortices, and bilateral hippocampal regions; [B]: control case (78-year-old patient with AD who did not develop delusions) mainly shows atrophy in bilateral hippocampal regions.

Discussion

The presently reported case exhibited various types of delusions during an 18-month period. Although her MRI findings showed bilateral hippocampal atrophy, other areas of atrophy, such as the bilateral insular cortex and the right orbitofrontal cortex, were also identified with VSRAD. Both the frontal and insular areas are thought to be linked with psychotic symptoms in AD patients.3,4 More importantly, before the onset of the delusions, the patient exhibited volume reductions in these areas. Thus, the abnormalities in both the frontal areas and the insulae likely reflect a pre-existing vulnerability in the present patient with AD who developed delusions. Further longitudinal study of a large sample of AD patients who develop delusions may be needed to clarify this hypothesis.

References

1.
McKhann G, Drachman D, Folstein M, et al.: Clinical Diagnosis of Alzheimer’s Disease: Report of the NINCDS-ADRDA Work Group Under the Auspices of the Dept. of Health and Human Services Task Force on Alzheimer’s Disease. Neurology 1984; 34:939–944
2.
Hirata Y, Matsuda H, Nemoto K, et al. Voxel-based morphometry to discriminate early Alzheimer’s disease from controls. Neurosci Lett 2005; 382:269–274
3.
Bruen PD, McGeown WJ, Shanks MF, et al.: Neuroanatomical correlates of neuropsychiatric symptoms in Alzheimer’s disease. Brain 2008; 131:2455–2463
4.
Matsuoka T, Narumoto J, Shibata K, et al.: Insular hypoperfusion correlates with the severity of delusions in individuals with Alzheimer’s disease. Dement Geriatr Cogn Disord 2010; 29:287–293

Information & Authors

Information

Published In

Go to The Journal of Neuropsychiatry and Clinical Neurosciences
Go to The Journal of Neuropsychiatry and Clinical Neurosciences
The Journal of Neuropsychiatry and Clinical Neurosciences
Pages: E65 - E66
PubMed: 24026751

History

Published online: 1 July 2013
Published in print: Summer 2013

Authors

Details

Shutaro Nakaaki, M.D., Ph.D.
Dept. of Neuropsychiatry Keio University School of Medicine Tokyo, Japan (SN, MM)Dept. of Psychiatry and Cognitive-Behavioral Medicine Nagoya City University Graduate School of Medical Sciences Nagoya, Japan (SN, JS, KT, TK, AK)Dept. of Radiology Nagoya City University Graduate School of Medical Sciences Nagoya, JapanDept. of Psychiatry Graduate School of Medical Science Kyoto Prefectural University of Medicine Kyoto, Japan (JN)
Junko Sato, Ph.D.
Dept. of Neuropsychiatry Keio University School of Medicine Tokyo, Japan (SN, MM)Dept. of Psychiatry and Cognitive-Behavioral Medicine Nagoya City University Graduate School of Medical Sciences Nagoya, Japan (SN, JS, KT, TK, AK)Dept. of Radiology Nagoya City University Graduate School of Medical Sciences Nagoya, JapanDept. of Psychiatry Graduate School of Medical Science Kyoto Prefectural University of Medicine Kyoto, Japan (JN)
Katsuyoshi Torii, M.D., Ph.D.
Dept. of Neuropsychiatry Keio University School of Medicine Tokyo, Japan (SN, MM)Dept. of Psychiatry and Cognitive-Behavioral Medicine Nagoya City University Graduate School of Medical Sciences Nagoya, Japan (SN, JS, KT, TK, AK)Dept. of Radiology Nagoya City University Graduate School of Medical Sciences Nagoya, JapanDept. of Psychiatry Graduate School of Medical Science Kyoto Prefectural University of Medicine Kyoto, Japan (JN)
Takatsune Kawaguchi, M.D., Ph.D.
Dept. of Neuropsychiatry Keio University School of Medicine Tokyo, Japan (SN, MM)Dept. of Psychiatry and Cognitive-Behavioral Medicine Nagoya City University Graduate School of Medical Sciences Nagoya, Japan (SN, JS, KT, TK, AK)Dept. of Radiology Nagoya City University Graduate School of Medical Sciences Nagoya, JapanDept. of Psychiatry Graduate School of Medical Science Kyoto Prefectural University of Medicine Kyoto, Japan (JN)
Akiko Kawaguchi, M.D., Ph.D.
Dept. of Neuropsychiatry Keio University School of Medicine Tokyo, Japan (SN, MM)Dept. of Psychiatry and Cognitive-Behavioral Medicine Nagoya City University Graduate School of Medical Sciences Nagoya, Japan (SN, JS, KT, TK, AK)Dept. of Radiology Nagoya City University Graduate School of Medical Sciences Nagoya, JapanDept. of Psychiatry Graduate School of Medical Science Kyoto Prefectural University of Medicine Kyoto, Japan (JN)
Jin Narumoto, M.D., Ph.D.
Dept. of Neuropsychiatry Keio University School of Medicine Tokyo, Japan (SN, MM)Dept. of Psychiatry and Cognitive-Behavioral Medicine Nagoya City University Graduate School of Medical Sciences Nagoya, Japan (SN, JS, KT, TK, AK)Dept. of Radiology Nagoya City University Graduate School of Medical Sciences Nagoya, JapanDept. of Psychiatry Graduate School of Medical Science Kyoto Prefectural University of Medicine Kyoto, Japan (JN)
Masaru Mimura, M.D., Ph.D.
Dept. of Neuropsychiatry Keio University School of Medicine Tokyo, Japan (SN, MM)Dept. of Psychiatry and Cognitive-Behavioral Medicine Nagoya City University Graduate School of Medical Sciences Nagoya, Japan (SN, JS, KT, TK, AK)Dept. of Radiology Nagoya City University Graduate School of Medical Sciences Nagoya, JapanDept. of Psychiatry Graduate School of Medical Science Kyoto Prefectural University of Medicine Kyoto, Japan (JN)

Notes

Correspondence: Dr. Shutaro Nakaaki; e-mail: [email protected]

Metrics & Citations

Metrics

Citations

Export Citations

If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Simply select your manager software from the list below and click Download.

For more information or tips please see 'Downloading to a citation manager' in the Help menu.

Format
Citation style
Style
Copy to clipboard

View Options

View options

PDF/EPUB

View PDF/EPUB

Login options

Already a subscriber? Access your subscription through your login credentials or your institution for full access to this article.

Personal login Institutional Login Open Athens login
Purchase Options

Purchase this article to access the full text.

PPV Articles - Journal of Neuropsychiatry and Clinical Neurosciences

PPV Articles - Journal of Neuropsychiatry and Clinical Neurosciences

Not a subscriber?

Subscribe Now / Learn More

PsychiatryOnline subscription options offer access to the DSM-5-TR® library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development.

Need more help? PsychiatryOnline Customer Service may be reached by emailing [email protected] or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.).

Media

Figures

Other

Tables

Share

Share

Share article link

Share